Skip to main content
Top
Published in: Orphanet Journal of Rare Diseases 1/2019

Open Access 01-12-2019 | Magnetic Resonance Imaging | Research

Thyroid involvement in Chanarin-Dorfman syndrome in adults in the largest series of patients carrying the same founder mutation in ABHD5 gene

Authors: Nacim Louhichi, Emna Bahloul, Slaheddine Marrakchi, Houda Ben Othman, Chahnez Triki, Kawthar Aloulou, Lobna Trabelsi, Nadia Mahfouth, Zeineb Ayadi-Mnif, Leila Keskes, Faiza Fakhfakh, Hamida Turki

Published in: Orphanet Journal of Rare Diseases | Issue 1/2019

Login to get access

Abstract

Background

Chanarin-Dorfman syndrome (CDS) is a rare syndromic disease related to an accumulation of triacylglycerol in most organs. The aim of our study was to investigate various organs in a large series of CDS patients.

Results

We report for the first time thyroid function impairment in CDS. Among 12 investigated patients, 7 showed thyroid function impairment. All of them were over 30 of age. The 5 remaining investigated patients with normal thyroid function were under 30. Thyroid loss of function is an unknown clinical feature of CDS that could gradually develop with age. Thyroid ultrasound showed an abnormal aspect in all investigated patients (6 with thyroid impairment and 3 with normal thyroid function). Cervical MRI done in 2 patients with thyroid impairment showed fat infiltration of thyroid parenchyma. Audiogram carried out in 8 of our patients showed sensorineural hearing impairment in all patients, although only 2 patients suffered from clinical hypoacusia. We also demonstrated that kidney could be a more commonly involved organ than previously reported in the literature. A poorly differentiated kidney parenchyma is a common feature in our series. One patient showed cerebellar atrophy and T2 hypersignal of brain’s white matter in MRI. All patients carried the same founder mutation c.773(− 1)G > A in the ABDH5 gene.

Discussion

Aside from the congenital ichthyosiform erythroderma, the most common symptom of CDS, in addition to other organs involvement frequently reported in the literature, we described thyroid dysfunction, an unreported feature, probably related to the lipid infiltration of the thyroid parenchyma. The association found between age and hypothyroidism in CDS patients could explain the gradually development of thyroid disease with age.

Conclusion

We reported a thyroid dysfunction and unreported ultrasonographic aspects of kidneys and cerebral MRI in CDS patients.

Methods

We performed clinical analyses in 15 patients in whom thyroid, liver, ocular, kidney, skeletal muscle and neurological involvement were explored. Genetic and molecular explorations were performed by direct sequence analysis. Software SPSS, Fisher’s exact test and ANOVA were used for statistical analyses.
Appendix
Available only for authorised users
Literature
1.
go back to reference Bruno C, Bertini E, Di Rocco M, et al. Clinical and genetic characterization of Chanarin-Dorfman syndrome. Biochem Biophys Res Commun. 2008;369(4):1125–8.CrossRef Bruno C, Bertini E, Di Rocco M, et al. Clinical and genetic characterization of Chanarin-Dorfman syndrome. Biochem Biophys Res Commun. 2008;369(4):1125–8.CrossRef
2.
go back to reference Williams ML, Koch TK, O'Donnell JJ, et al. Ichthyosis and neutral lipid storage disease. Am J Med Genet. 1985;20(4):711–26.CrossRef Williams ML, Koch TK, O'Donnell JJ, et al. Ichthyosis and neutral lipid storage disease. Am J Med Genet. 1985;20(4):711–26.CrossRef
3.
go back to reference Peña-Penabad C, Almagro M, Martínez W, et al. Dorfman--Chanarin syndrome (neutral lipid storage disease): new clinical features. Br J Dermatol. 2001;144(2):430–2.CrossRef Peña-Penabad C, Almagro M, Martínez W, et al. Dorfman--Chanarin syndrome (neutral lipid storage disease): new clinical features. Br J Dermatol. 2001;144(2):430–2.CrossRef
4.
go back to reference Lefèvre C, Jobard F, Caux F, et al. Mutations in CGI-58, the gene encoding a new protein of the esterase/lipase/thioesterase subfamily, in Chanarin-Dorfman syndrome. Am J Hum Genet. 2001;69(5):1002–12.CrossRef Lefèvre C, Jobard F, Caux F, et al. Mutations in CGI-58, the gene encoding a new protein of the esterase/lipase/thioesterase subfamily, in Chanarin-Dorfman syndrome. Am J Hum Genet. 2001;69(5):1002–12.CrossRef
5.
go back to reference Lass A, Zimmermann R, Haemmerle G, et al. Adipose triglyceride lipase-mediated lipolysis of cellular fat stores is activated by CGI-58 and defective in Chanarin-Dorfman syndrome. Cell Metab. 2006;3(5):309–19.CrossRef Lass A, Zimmermann R, Haemmerle G, et al. Adipose triglyceride lipase-mediated lipolysis of cellular fat stores is activated by CGI-58 and defective in Chanarin-Dorfman syndrome. Cell Metab. 2006;3(5):309–19.CrossRef
6.
go back to reference Zhao M, Tang X, Yang T, et al. Lipotoxicity, a potential risk factor for the increasing prevalence of subclinical hypothyroidism? J Clin Endocrinol Metab. 2015;100(5):1887–94.CrossRef Zhao M, Tang X, Yang T, et al. Lipotoxicity, a potential risk factor for the increasing prevalence of subclinical hypothyroidism? J Clin Endocrinol Metab. 2015;100(5):1887–94.CrossRef
7.
go back to reference Zhao M, Zhang X, Gao L, et al. Palmitic acid downregulates thyroglobulin (Tg), sodium iodide symporter (NIS), and Thyroperoxidase (TPO) in human primary Thyrocytes: a potential mechanism by which lipotoxicity affects thyroid? Int J Endocrinol. 2018;17:4215848. Zhao M, Zhang X, Gao L, et al. Palmitic acid downregulates thyroglobulin (Tg), sodium iodide symporter (NIS), and Thyroperoxidase (TPO) in human primary Thyrocytes: a potential mechanism by which lipotoxicity affects thyroid? Int J Endocrinol. 2018;17:4215848.
8.
go back to reference Aksu G, Kalkan Ucar S, Bulut Y, et al. Renal involvement as a rare complication of Dorfman-Chanarin syndrome: a case report. Pediatr Dermatol. 2008;25(3):326–31.CrossRef Aksu G, Kalkan Ucar S, Bulut Y, et al. Renal involvement as a rare complication of Dorfman-Chanarin syndrome: a case report. Pediatr Dermatol. 2008;25(3):326–31.CrossRef
9.
go back to reference Cakmak E, Alagozlu H, Yonem O, et al. Steatohepatitis and liver cirrhosis in Chanarin-Dorfman syndrome with a new ABDH5 mutation. Clin Res Hepatol Gastroenterol. 2012;36(2):e34–7.CrossRef Cakmak E, Alagozlu H, Yonem O, et al. Steatohepatitis and liver cirrhosis in Chanarin-Dorfman syndrome with a new ABDH5 mutation. Clin Res Hepatol Gastroenterol. 2012;36(2):e34–7.CrossRef
10.
go back to reference Srinivasan R, Hadzić N, Fischer J, Knisely AS. Steatohepatitis and unsuspected micronodular cirrhosis in Dorfman-Chanarin syndrome with documented ABHD5 mutation. J Pediatr. 2004;144(5):662–5.CrossRef Srinivasan R, Hadzić N, Fischer J, Knisely AS. Steatohepatitis and unsuspected micronodular cirrhosis in Dorfman-Chanarin syndrome with documented ABHD5 mutation. J Pediatr. 2004;144(5):662–5.CrossRef
11.
go back to reference Gupta N, Gothwal S, Satpathy AK, et al. Chanarin Dorfman syndrome: a case report with novel nonsense mutation. Gene. 2016;575(2 Pt1):359–62.CrossRef Gupta N, Gothwal S, Satpathy AK, et al. Chanarin Dorfman syndrome: a case report with novel nonsense mutation. Gene. 2016;575(2 Pt1):359–62.CrossRef
12.
go back to reference Hollowell JG, Staehling NW, Flanders WD, et al. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and nutrition examination survey (NHANES III). J Clin Endocrinol Metab. 2002;87(2):489–99.CrossRef Hollowell JG, Staehling NW, Flanders WD, et al. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and nutrition examination survey (NHANES III). J Clin Endocrinol Metab. 2002;87(2):489–99.CrossRef
13.
go back to reference Chabchoub G, Mnif M, Maalej A, et al. Epidemiologic study of autoimmune thyroid disease in South Tunisia. Ann Endocrinol. 2006;67(6):591–5.CrossRef Chabchoub G, Mnif M, Maalej A, et al. Epidemiologic study of autoimmune thyroid disease in South Tunisia. Ann Endocrinol. 2006;67(6):591–5.CrossRef
14.
go back to reference Huigen MC, van der Graaf M, Morava E, et al. Cerebral lipid accumulation in Chanarin-Dorfman syndrome. Mol Genet Metab. 2015;114(1):51–4.CrossRef Huigen MC, van der Graaf M, Morava E, et al. Cerebral lipid accumulation in Chanarin-Dorfman syndrome. Mol Genet Metab. 2015;114(1):51–4.CrossRef
15.
go back to reference Redaelli C, Coleman RA, Moro L, et al. Clinical and genetic characterization of Chanarin-Dorfman syndrome patients: first report of large deletions in the ABHD5 gene. Orphanet J Rare Dis. 2010;5(1):33.CrossRef Redaelli C, Coleman RA, Moro L, et al. Clinical and genetic characterization of Chanarin-Dorfman syndrome patients: first report of large deletions in the ABHD5 gene. Orphanet J Rare Dis. 2010;5(1):33.CrossRef
16.
go back to reference Verma SB, Mittal A, Wollina U, et al. Chanarin-Dorfman syndrome with rare renal involvement. Br J Dermatol. 2017;176(2):545–8.CrossRef Verma SB, Mittal A, Wollina U, et al. Chanarin-Dorfman syndrome with rare renal involvement. Br J Dermatol. 2017;176(2):545–8.CrossRef
17.
go back to reference Nur BG, Gencpinar P, Yuzbasıoglu A, et al. Chanarin-Dorfman syndrome: genotype-phenotype correlation. Eur J Med Genet. 2015;58(4):238–42.CrossRef Nur BG, Gencpinar P, Yuzbasıoglu A, et al. Chanarin-Dorfman syndrome: genotype-phenotype correlation. Eur J Med Genet. 2015;58(4):238–42.CrossRef
18.
go back to reference Guo F, Ma Y, Kadegowda AK, et al. Deficiency of liver comparative gene Identification-58 causes steatohepatitis and fibrosis in mice. J Lipid Res. 2013;54(8):2109–20.CrossRef Guo F, Ma Y, Kadegowda AK, et al. Deficiency of liver comparative gene Identification-58 causes steatohepatitis and fibrosis in mice. J Lipid Res. 2013;54(8):2109–20.CrossRef
19.
go back to reference Barnérias C, Bassez G, Schischmanoff O. Chanarin-Dorfman syndrome in a 7-year-old child: when myophathy and skin involvement are all but one. Med Sci(Paris). 2015;31 Spec No 3:11–13. Barnérias C, Bassez G, Schischmanoff O. Chanarin-Dorfman syndrome in a 7-year-old child: when myophathy and skin involvement are all but one. Med Sci(Paris). 2015;31 Spec No 3:11–13.
20.
go back to reference Sugiura K, Suga Y, Akiyama M. Dorfman-Chanarin syndrome without mental retardation caused by a homozygous ABHD5 splice site mutation that skips exon 6. J Dermatol Sci. 2014;75(3):199–201.CrossRef Sugiura K, Suga Y, Akiyama M. Dorfman-Chanarin syndrome without mental retardation caused by a homozygous ABHD5 splice site mutation that skips exon 6. J Dermatol Sci. 2014;75(3):199–201.CrossRef
21.
go back to reference Romdhane L, Kefi R, Azaiez H, et al. Founder mutations in Tunisia: implications for diagnosis in North Africa and Middle East. Orphanet J Rare Dis. 2012;7:52.CrossRef Romdhane L, Kefi R, Azaiez H, et al. Founder mutations in Tunisia: implications for diagnosis in North Africa and Middle East. Orphanet J Rare Dis. 2012;7:52.CrossRef
Metadata
Title
Thyroid involvement in Chanarin-Dorfman syndrome in adults in the largest series of patients carrying the same founder mutation in ABHD5 gene
Authors
Nacim Louhichi
Emna Bahloul
Slaheddine Marrakchi
Houda Ben Othman
Chahnez Triki
Kawthar Aloulou
Lobna Trabelsi
Nadia Mahfouth
Zeineb Ayadi-Mnif
Leila Keskes
Faiza Fakhfakh
Hamida Turki
Publication date
01-12-2019
Publisher
BioMed Central
Published in
Orphanet Journal of Rare Diseases / Issue 1/2019
Electronic ISSN: 1750-1172
DOI
https://doi.org/10.1186/s13023-019-1095-4

Other articles of this Issue 1/2019

Orphanet Journal of Rare Diseases 1/2019 Go to the issue